Vascular Biogenics Ltd (VBLT)

[staccani]

And I tell you one more thing. In June 2016 there were already 17 patients on trial so this means that all started at least 17 months ago. You look at the 9th patients in the surviving list and he survived 15.7 months, so it easy to guess that all the non shown patients (8) have lived less than 15.7m (basically the ones not reported in the slide, are all dead, earlier than 15.7m). So the 15.7m median survival is the most reasonable estimate we can make. Obviously the company knows, so I hope they will show the surviving times of all the 17 patients sooner than later and correct the mOS in the prOC ph2 trial